215 related articles for article (PubMed ID: 31365924)
1. Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.
Volk CF; Burgdorf S; Edwardson G; Nizet V; Sakoulas G; Rose WE
Clin Infect Dis; 2020 Jun; 70(12):2634-2640. PubMed ID: 31365924
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
4. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
[TBL] [Abstract][Full Text] [Related]
5. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Wong D; Wong T; Romney M; Leung V
BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
[TBL] [Abstract][Full Text] [Related]
7. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
Trials; 2018 May; 19(1):297. PubMed ID: 29843781
[TBL] [Abstract][Full Text] [Related]
9. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Wong D; Wong T; Romney M; Leung V
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Dhand A; Sakoulas G
Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
[TBL] [Abstract][Full Text] [Related]
14. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J
Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Holubar M; Meng L; Deresinski S
Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
[TBL] [Abstract][Full Text] [Related]
17. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.
Rose WE; Shukla SK; Berti AD; Hayney MS; Henriquez KM; Ranzoni A; Cooper MA; Proctor RA; Nizet V; Sakoulas G
Clin Infect Dis; 2017 May; 64(10):1406-1412. PubMed ID: 28205673
[TBL] [Abstract][Full Text] [Related]
18. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
19. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2019.
Coombs GW; Daley DA; Mowlaboccus S; Pang S;
Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988337
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]